Chakma Justin — SEC Form 4 filings
SEC reporting owner CIK 1951238. 8 Form 4 filings on record with FilingPulse; latest filed 2026-01-05.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-11-27 to 2026-01-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 13 legs across 6 filings — 695,625 shares, $8,563,427 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
- Largest priced transaction: sale of 117,333 shares @ $12.27 ($1,439,124) in ARS Pharmaceuticals, Inc., filed 2024-12-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ARS Pharmaceuticals, Inc. (SPRY) | Chief Business Officer | 8 | — | 13 legs · 695,625 sh · $8,563,427 | 22 |
Form 4 filings — Chakma Justin
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-05 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Grant/award (A): 240,000 (derivative) @ $0 | EDGAR |
| 2025-11-14 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Option exercise (M): 30,000 @ $0.84 · Sale (S): 30,000 @ $8.91 · Sale (S): 136,380 @ $8.86 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Grant/award (A): 274,100 (derivative) @ $0 | EDGAR |
| 2024-12-13 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Option exercise (M): 117,333 @ $0.84 · Sale (S): 117,333 @ $12.27 · Option exercise (M): 27,272 @ $1.44 · Sale (S): 27,272 @ $12.06 · Option exercise (M): 117,333 (derivative) @ $0 · Option exercise (M): 27,272 (derivative) @ $0 | EDGAR |
| 2024-12-12 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Option exercise (M): 50,000 @ $0.84 · Sale (S): 50,000 @ $13.15 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2024-12-06 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Option exercise (M): 45,000 @ $0.84 · Sale (S): 45,000 @ $13.95 · Option exercise (M): 49,640 @ $0.84 · Sale (S): 49,640 @ $14.13 · Option exercise (M): 50,000 @ $0.84 · Sale (S): 50,000 @ $14.23 · +3 more | EDGAR |
| 2024-12-04 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Option exercise (M): 45,000 @ $0.84 · Sale (S): 45,000 @ $13.67 · Option exercise (M): 3,260 @ $0.84 · Option exercise (M): 41,740 @ $0.84 · Sale (S): 45,000 @ $13.19 · Option exercise (M): 45,000 (derivative) @ $0 · +2 more | EDGAR |
| 2024-11-27 | 4 | ARS Pharmaceuticals, Inc. (SPRY) | Sale (S): 32,814 @ $14.00 · Sale (S): 42,186 @ $14.05 · Sale (S): 25,000 @ $14.39 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1951238 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →